Mir-204-5p通过针对糖尿病白内障中的IGFBP5来缓解线粒体功能障碍
Jin Xie1,2, Peng Chen3,4, Shilan Mao5,6
1State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingdao, China.
Molecular biology reports
|June 14, 2024
概括
微RNA-204-5p通过维持线粒体功能来保护糖尿病白内障. 它通过抑制胰岛素样生长因子结合蛋白5 (IGFBP5) 来实现这一目标,这表明IGFBP5是潜在的治疗标.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病白内障 (DC) 是视力障碍的重要原因,由糖尿病加剧.
- 在白内障患者,特别是DC患者中观察到miR-204-5p表达的减少.
- 在DC病原体中miR-204-5p的确切作用尚不清楚.
研究的目的:
- 研究miR-204-5p在糖尿病白内障发展中的作用和机制.
- 在人类镜片上皮细胞中识别miR-204-5p的分子标.
主要方法:
- 在白内障患者的透镜中分析miR-204-5p表达.
- 建立由过氧化诱导的人类透镜上皮细胞 (HLEC) 白内障模型.
- 生物信息学分析,露西法酶测定,免疫光染色和西部斑点来识别miR-204-5p目标.
- 评估线粒体膜潜力 (MMP) 和IGFBP5表达.
主要成果:
- 在DC患者透镜和HLEC白内障模型中,线粒体膜潜力 (MMP) 降低了.
- 在HLEC中,miR-204-5p Knockdown进一步降低了MMP.
- 胰岛素类生长因子结合蛋白5 (IGFBP5) 被确定为miR-204-5p的直接标.
- 在DC镜头和HLEC模型中,IGFBP5表达升高;它的敲击逆转了线粒体功能障碍.
结论:
- miR-204-5p通过抑制IGFBP5表达来保持线粒体的完整性.
- IGFBP5成为糖尿病白内障的潜在治疗标和预后标志物.
更多相关视频
05:19Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
1.0K
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
164
相关概念视频
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...